A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following a ...

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Shares of the vaccine maker Moderna gained traction recently due to its updates of its vaccine trials with bang up results.

Additional research efforts are also focusing on RSV, Rift Valley Fever ... Fried underscored that the network established ...

US health officials have approved vaccines for respiratory syncytial virus (RSV), an infection that can be deadly for some ...

Take an at-home COVID test when you feel sick, or go to an urgent care where you can be tested for COVID, RSV, and influenza ...

With family gatherings for the holidays approaching along with the beginning of the ski season, this is the time for ...

Those with adverse effects from the Pfizer or Moderna mRNA COVID vaccines should consider the Novavax recombinant spike ...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look ...

Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored ...

Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical trial in China on Wednesday, as an adult received a shot at a clinical ...